Skip to content

Clinical trials

Recurrence trials in Lithuania

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Recurrence Country / region: Lithuania Clear all

16 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20072
20081
20101
20111
20121
20131
20151
20161
20191
20211
20242
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed9
Recruiting3
Terminated2
Active, not recruiting1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Amgen2
Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS2
Janssen-Cilag International NV2
Novartis Pharmaceuticals2
Abbott Medical Devices1
Genmab1
Henrik Gregersen1
Millennium Pharmaceuticals, Inc.1
PCI Biotech AS1
Prof. Dr. Med. Laimonas Griskevicius1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Recurrence16
Multiple Myeloma3
Multiple Sclerosis3
Leukemia, Myeloid, Acute2
Neoplasms2
Atrial Fibrillation1
Bone Marrow Neoplasms1
Carcinoma, Squamous Cell1
Disease1
Endometrial Neoplasms1

Trials

Showing 1 to 16 of 16. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.